Phase 3 Stomach Cancer Trial, Recruiting (NCT07488611)

Phase 3 Stomach Cancer Trial, Recruiting NCT07488611 Sponsor: Soonchunhyang University Hospital Condition: Stomach Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07488611 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stomach Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 19 years or older who are scheduled to have surgery for gastric (stomach) cancer.
People who have given their written agreement to take part in this study.

Who may not be able to join:

People who have a serious uncontrolled illness, such as poorly managed diabetes, a stroke or similar brain/blood vessel event within the past 6 months, a severe widespread infection (sepsis), or heart failure.
People who have received nutrition delivered directly into a vein (intravenous feeding) within the 7 days before being enrolled in the study.
People whose pre-surgery blood tests show certain significant abnormalities, including very high fat (triglyceride) levels in the blood, abnormal liver function markers, abnormal kidney function markers, poor long-term blood sugar control, or abnormal levels of certain minerals such as potassium, calcium, sodium, or magnesium (confirm specific test values with trial site).
People whom the doctor running the trial considers unsuitable for participation for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Geum Jong Song, MD, PhD, Soonchunhyang University Hospital

Phone: +82-10-3328-4380

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07488611

Sponsor: Soonchunhyang University Hospital

Phase: Phase 3

Status: Recruiting

Condition: Stomach Cancer

Trial contact: +82-10-3328-4380

More information: https://clinicaltrials.gov/study/NCT07488611

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 19 years or older who are scheduled to have surgery for gastric (stomach) cancer.
People who have given their written agreement to take part in this study.

Who may not be able to join:

People who have a serious uncontrolled illness, such as poorly managed diabetes, a stroke or similar brain/blood vessel event within the past 6 months, a severe widespread infection (sepsis), or heart failure.
People who have received nutrition delivered directly into a vein (intravenous feeding) within the 7 days before being enrolled in the study.
People whose pre-surgery blood tests show certain significant abnormalities, including very high fat (triglyceride) levels in the blood, abnormal liver function markers, abnormal kidney function markers, poor long-term blood sugar control, or abnormal levels of certain minerals such as potassium, calcium, sodium, or magnesium (confirm specific test values with trial site).
People whom the doctor running the trial considers unsuitable for participation for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 3

Sponsor

Soonchunhyang University Hospital

Registry

ClinicalTrials.gov

Start date

13 February 2026

Est. completion

1 February 2027

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Nitrogen Balance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov